Cystic Fibrosis Devices - Global Strategic Business Report

The global market for Cystic Fibrosis Devices is estimated at US$850.8 Million in 2023 and is projected to reach US$1.6 Billion by 2030, growing at a CAGR of 9.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Key Insights:

Regional Analysis: Gain insights into the U.S. market, estimated at $221.9 Million in 2023, and China, forecasted to grow at an impressive 13.5% CAGR to reach $410.4 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

Detailed Market Analysis: Access a thorough analysis of the Global Cystic Fibrosis Devices Market, covering all major geographic regions and market segments.
Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Cystic Fibrosis Devices Market.
Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

How is the Global Cystic Fibrosis Devices Market expected to evolve by 2030?
What are the main drivers and restraints affecting the market?
Which market segments will grow the most over the forecast period?
How will market shares for different regions and segments change by 2030?
Who are the leading players in the market, and what are their prospects?

Report Features:

Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of major players such as AbbVie, Allergan Plc, AstraZeneca, and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 42 Featured):

AbbVie
Allergan Plc
AstraZeneca
Bayer AG
Chiesi Farmaceutici S.p.A.
F. Hoffmann-La Roche AG
Genentech, Inc.
Gilead Sciences
Mylan N.V.
Novartis AG
Pfizer Inc.
Pharmaxis Ltd.
PTC Therapeutics
Vertex Pharmaceuticals Incorporated

MarketGlass Platform

Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.

I. METHODOLOGYII. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Influencer Market Insights
World Market Trajectories
Global Economic Update
Cystic Fibrosis Devices - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)

2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

Table 1: World Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 2: World Historic Review for Cystic Fibrosis Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 3: World 16-Year Perspective for Cystic Fibrosis Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
Table 4: World Cystic Fibrosis Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

UNITED STATES

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
Table 5: USA Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 6: USA Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

CANADA

Table 7: Canada Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 8: Canada Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

JAPAN

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
Table 9: Japan Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 10: Japan Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

CHINA

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
Table 11: China Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 12: China Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

EUROPE

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
Table 13: Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 14: Europe Historic Review for Cystic Fibrosis Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 15: Europe 16-Year Perspective for Cystic Fibrosis Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030

FRANCE

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
Table 16: France Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 17: France Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

GERMANY

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
Table 18: Germany Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 19: Germany Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

ITALY

Table 20: Italy Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 21: Italy Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

UNITED KINGDOM

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
Table 22: UK Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 23: UK Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

SPAIN

Table 24: Spain Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 25: Spain Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

RUSSIA

Table 26: Russia Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 27: Russia Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

REST OF EUROPE

Table 28: Rest of Europe Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 29: Rest of Europe Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

ASIA-PACIFIC

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
Table 30: Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 31: Asia-Pacific Historic Review for Cystic Fibrosis Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 32: Asia-Pacific 16-Year Perspective for Cystic Fibrosis Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030

AUSTRALIA

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
Table 33: Australia Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 34: Australia Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

INDIA

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
Table 35: India Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 36: India Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

SOUTH KOREA

Table 37: South Korea Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 38: South Korea Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

REST OF ASIA-PACIFIC

Table 39: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 40: Rest of Asia-Pacific Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

LATIN AMERICA

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
Table 41: Latin America Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 42: Latin America Historic Review for Cystic Fibrosis Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 43: Latin America 16-Year Perspective for Cystic Fibrosis Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030

ARGENTINA

Table 44: Argentina Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 45: Argentina Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

BRAZIL

Table 46: Brazil Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 47: Brazil Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

MEXICO

Table 48: Mexico Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 49: Mexico Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

REST OF LATIN AMERICA

Table 50: Rest of Latin America Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 51: Rest of Latin America Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

MIDDLE EAST

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
Table 52: Middle East Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
Table 53: Middle East Historic Review for Cystic Fibrosis Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
Table 54: Middle East 16-Year Perspective for Cystic Fibrosis Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030

IRAN

Table 55: Iran Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 56: Iran Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

ISRAEL

Table 57: Israel Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 58: Israel Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

SAUDI ARABIA

Table 59: Saudi Arabia Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 60: Saudi Arabia Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

UNITED ARAB EMIRATES

Table 61: UAE Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 62: UAE Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

REST OF MIDDLE EAST

Table 63: Rest of Middle East Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 64: Rest of Middle East Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

AFRICA

Cystic Fibrosis Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
Table 65: Africa Recent Past, Current & Future Analysis for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
Table 66: Africa Historic Review for Cystic Fibrosis Devices by Segment - Cystic Fibrosis Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR

IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AbbVie
Allergan Plc
AstraZeneca
Bayer AG
Chiesi Farmaceutici S.p.A.
F. Hoffmann-La Roche AG
Genentech, Inc.
Gilead Sciences
Mylan N.V.
Novartis AG
Pfizer Inc.
Pharmaxis Ltd.
PTC Therapeutics
Vertex Pharmaceuticals Incorporated

Table Information

Report Attribute	Details
No. of Pages	93
Published	November 2024
Forecast Period	2023 - 2030
Estimated Market Value ( USD ) in 2023	$ 850.8 Million
Forecasted Market Value ( USD ) by 2030	$ 1600 Million
Compound Annual Growth Rate	9.1%
Regions Covered	Global

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€5378EUR$5,600USD£4,489GBP
1 - 10 USER LICENSE PDF	The product is a PDF.	This is a 1-10 user license, allowing up to ten users have access to the product.	€10217EUR$10,640USD£8,529GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€16133EUR$16,800USD£13,467GBP

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Select Competitors (Total 42 Featured):

MarketGlass Platform

Table of Contents

Companies Mentioned (Partial List)

Table Information

Related Topics

Related Reports

Non-Cystic Fibrosis Bronchiectasis Market Report 2024

Cystic Fibrosis Market - Forecasts from 2024 to 2029

Non-Cystic Fibrosis Bronchiectasis Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

Cystic Fibrosis Market Analysis & Forecast to 2024-2034

Cystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update